[Meet] Dr Gerald Maarman, a nominee contending for the TW Kambule-NSTF Researcher Award, sponsored by proSET, a sector of the NSTF representing almost 50 professional societies! He is a Sr lecturer: Division of Medical Physiology, Dept of Biomedical Sciences, Faculty of

Thank you, Dr. Thienemann from 🇿🇦, for an excellent webinar! If you missed it, don't worry—it will be uploaded on the The Pulmonary Vascular Research Institute website in a few days. iPVD consortium

Interstitial macrophage phenotypes in Schistosoma-induced pulmonary hypertension Rahul Kumar Rahul Kumar , Sushil Kumar, Claudia Mickael, et al

I am proud to share this excellent collaboration with Drs. Grazyna Kwapiszewska and Slaven Crnovic with you all. Check it out! Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease biorxiv.org/content/10.110…

The countdown has begun! pvrilatam2024.com.br

Congratulations to Vascular Medicine Institute investigator Samit Ghosh pioneering the mechanisms of renal complications of sickle cell disease!

After her PhD viva today, Christine is now Dr MC Masong and an important contribution to multidisciplinary studies on #FGSchisto in Cameroon – congratualtions et felicitations! pubmed.ncbi.nlm.nih.gov/38547346/ pubmed.ncbi.nlm.nih.gov/36787976/ pubmed.ncbi.nlm.nih.gov/36962084/ pubmed.ncbi.nlm.nih.gov/33012861/

Was great to talk autonomic dysfunction, persistent infection and related topics at this session today. Check it out! 🤓

A year ago today, after a successful infection and pulmonary vascular diseases conference iPVD consortium, we enjoyed a cultural visit to one of Athens' highlights. Reflecting on the enriching experience and the beauty of this glorious city.Navneet Dhillon Vinicio de Jesus Perez, MD FAHA FCCP ATSF Pullamsetti Lab

We remind you that the proceedings of #WSPH2024 will be published in a regular issue of ERS publications by the end of August. Open access/ Open science EMBARGO till 29 August 2024

Pre-order your print copy of the ERS Monograph "COVID-19: An Update" before 18 August and receive a €10 discount ow.ly/P2Pr50SFRrj

Temporal Trends in HIV Prevalence, Antiretroviral Therapy Coverage, Incidence of Tuberculosis, and Deaths from Tuberculosis in South Africa, 1990–2020. Read more in "HIV-Associated Tuberculosis" by Drs. Graeme Meintjes & Gary Maartens: nej.md/3LCGmHD

Dr. Thenappan is a member of the Advanced Heart Failure Section and Leader of the Pulmonary Hypertension Program at the University of Minnesota. Faculty Bio: med.umn.edu/bio/thenappan-…

In 1980, Ethiopia had the highest death rate from tuberculosis in the world. Almost 400 people died per 100,000 people, according to data from the latest edition of the Global Burden of Disease study. Since then, the country has achieved a sixfold reduction in the death rate.

🎙️TIPS to researches, especially internationally trained: 🤝Cherish human bonding 🫂Find value in mentoring 🌈 Embrace diversity 🦾Combine past/current strengths ☀️Focus on the bright side 📈Be ambitious and persistent Together we'll continue to make🌎🌍🌏a better place!

At the International PH Forum and Reception, people with #PH and leaders from international #pulmonaryhypertension associations discussed key challenges people with PH face globally and how to best support them. #PHA2024

From the microbiome to the microtubules: Latest preprint led by Sasha Prisco, MD, PhD showing the anti-inflammatory bacteria Lactobacillus can counteract systemic inflammation-associated microtubule remodeling in RV failure. biorxiv.org/content/10.110… 3CPR Council The Pulmonary Vascular Research Institute U of M Research

Pathogenic microbes blown vast distances by winds, scientists discover - Living microbes that cause disease in humans and host antibiotic-resistance genes carried 2000km Story by me theguardian.com/science/articl…